These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 26959073)

  • 1. The prognostic role of FIGO stage in patients with vulvar cancer: a systematic review and meta-analysis.
    Zhou J; Shan G
    Curr Med Res Opin; 2016 Jun; 32(6):1121-30. PubMed ID: 26959073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the number and laterality of metastatic inguinal lymph nodes in vulvar cancer: revisiting the FIGO staging system.
    Baiocchi G; Silva Cestari FM; Rocha RM; Lavorato-Rocha A; Maia BM; Cestari LA; Kumagai LY; Faloppa CC; Fukazawa EM; Badiglian-Filho L; Sant'ana Rodrigues I; Soares FA
    Eur J Surg Oncol; 2013 Jul; 39(7):780-5. PubMed ID: 23518307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymph node ratio as an indicator of nodal status in the assessment of survival and recurrence in vulvar cancer: A cohort study.
    Mansouri H; Zemni I; Sakhri S; Ayadi MA; Boujelbene N; Ben Dhiab T
    Womens Health (Lond); 2024; 20():17455057241285396. PubMed ID: 39340307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance and prognostic value of femoral lymph node metastasis in FIGO stage III vulvar carcinoma.
    Tu H; Sun P; Gu HF; Zhang XK; Huang H; Wan T; Liu JH
    Eur J Surg Oncol; 2017 Sep; 43(9):1768-1775. PubMed ID: 28602173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of lymph node ratio and number of positive inguinal nodes in patients with vulvar cancer.
    Polterauer S; Schwameis R; Grimm C; Macuks R; Iacoponi S; Zalewski K; Zapardiel I;
    Gynecol Oncol; 2017 Oct; 147(1):92-97. PubMed ID: 28797698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
    Polterauer S; Schwameis R; Grimm C; Hillemanns P; Jückstock J; Hilpert F; de Gregorio N; Hasenburg A; Sehouli J; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Harter P; Wimberger P; Kölbl H; Reinthaller A; Woelber L; Mahner S
    Gynecol Oncol; 2019 May; 153(2):286-291. PubMed ID: 30760408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution.
    Tabbaa ZM; Gonzalez J; Sznurkowski JJ; Weaver AL; Mariani A; Cliby WA
    Gynecol Oncol; 2012 Oct; 127(1):147-52. PubMed ID: 22704951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer.
    Tantipalakorn C; Robertson G; Marsden DE; Gebski V; Hacker NF
    Obstet Gynecol; 2009 Apr; 113(4):895-901. PubMed ID: 19305336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome After Sentinel Lymph Node Dissection in Vulvar Cancer: A Subgroup Analysis of the AGO-CaRE-1 Study.
    Klapdor R; Hillemanns P; Wölber L; Jückstock J; Hilpert F; de Gregorio N; Iborra S; Sehouli J; Habermann A; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Meier W; Harter P; Wimberger P; Hanker L; Schmalfeldt B; Canzler U; Fehm T; Luyten A; Hellriegel M; Kosse J; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Richter B; Jäger M; Mahner S
    Ann Surg Oncol; 2017 May; 24(5):1314-1321. PubMed ID: 27896515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study.
    Minig L; Heitz F; Cibula D; Bakkum-Gamez JN; Germanova A; Dowdy SC; Kalogera E; Zapardiel I; Lindemann K; Harter P; Scambia G; Petrillo M; Zorrero C; Zanagnolo V; Rebollo JMC; du Bois A; Fotopoulou C
    Ann Surg Oncol; 2017 Sep; 24(9):2720-2726. PubMed ID: 28608122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The number of removed lymph nodes by inguinofemoral lymphadenectomy: impact on recurrence rates in patients with vulva carcinoma.
    Diehl A; Volland R; Kirn V; Thangarajah F; Eichler C; Einzmann T; Wirtz M; Ratiu D; Morgenstern B; Fridrich C; Mallmann P; Puppe J
    Arch Gynecol Obstet; 2016 Jul; 294(1):131-6. PubMed ID: 26498758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
    Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcomes for patients with stage IVB vulvar cancer with grossly positive pelvic lymph nodes: time to reconsider the FIGO staging system?
    Thaker NG; Klopp AH; Jhingran A; Frumovitz M; Iyer RB; Eifel PJ
    Gynecol Oncol; 2015 Feb; 136(2):269-73. PubMed ID: 25524458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness of radical therapy in vulvar carcinoma. An analysis of 148 cases].
    Bokhman JV; Maximov SJ; Ebert AD
    Zentralbl Gynakol; 1997; 119(4):166-72. PubMed ID: 9206922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of stage and age on survival of patients with vulvar cancer in Germany: a retrospective study.
    Mack LC; Hagemeier A; Forner DM
    BMJ Open; 2024 Aug; 14(8):e077960. PubMed ID: 39209505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A suggested modification to FIGO stage III vulvar cancer.
    Rouzier R; Preti M; Sideri M; Paniel BJ; Jones RW
    Gynecol Oncol; 2008 Jul; 110(1):83-6. PubMed ID: 18436291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study.
    Klapdor R; Wölber L; Hanker L; Schmalfeldt B; Canzler U; Fehm T; Luyten A; Hellriegel M; Kosse J; Heiss C; Hantschmann P; Mallmann P; Tanner B; Pfisterer J; Jückstock J; Hilpert F; de Gregorio N; Hillemanns P; Fürst ST; Mahner S
    Gynecol Oncol; 2019 Sep; 154(3):565-570. PubMed ID: 31227222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Staging for vulvar cancer.
    Hacker NF; Barlow EL
    Best Pract Res Clin Obstet Gynaecol; 2015 Aug; 29(6):802-11. PubMed ID: 25842047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vulvar squamous cell carcinoma. Prognostic factors for local recurrence after primary en bloc radical vulvectomy and bilateral groin dissection.
    Fonseca-Moutinho JA; Coelho MC; Silva DP
    J Reprod Med; 2000 Aug; 45(8):672-8. PubMed ID: 10986688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of clinical versus surgical staging systems in vulvar cancer.
    Shanbour KA; Mannel RS; Morris PC; Yadack A; Walker JL
    Obstet Gynecol; 1992 Dec; 80(6):927-30. PubMed ID: 1448261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.